Investigation of the risk factors in the development of radionecrosis in patients with brain metastases undergoing stereotactic radiotherapy

被引:1
作者
Dogan, Bedriye [1 ]
Demir, Harun [2 ]
Isik, Naciye [3 ]
Gunalp, Gun [3 ]
Gunbey, Hediye Pinar [4 ]
Yaprak, Gokhan [3 ]
机构
[1] Inonu Univ, Fac Med, Dept Radiat Oncol, TR-44280 Malatya, Turkiye
[2] Konya City Hosp, Dept Radiat Oncol, TR-42020 Konya, Turkiye
[3] Kartal Dr Lutfi Kirdar City Hosp, Dept Radiat Oncol, TR-34100 Istanbul, Turkiye
[4] Kartal Dr Lutfi Kirdar City Hosp, Dept Radiol, TR-34100 Istanbul, Turkiye
关键词
brain metastasis; radionecrosis; stereotactic radiosurgery; stereotactic radiotherapy; RADIATION NECROSIS; CEREBRAL METASTASES; RADIOSURGERY; THERAPY; VOLUME; CONFORMITY; PREDICTOR; CRITERIA; CANCER; INJURY;
D O I
10.1093/bjr/tqae051
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: To investigate the incidence, timing, and the factors predictors radionecrosis (RN) development in brain metastases (BMs) undergoing stereotactic radiotherapy (SRT). Methods: The study evaluated 245 BMs who exclusively received SRT between 2010 and 2020. RN was detected pathologically or radiologically. Results: The median of follow-up was 22.6 months. RN was detected in 18.4% of the metastatic lesions, and 3.3% symptomatic, 15.1% asymptomatic. The median time of RN was 22.8 months (2.5-39.5), and the rates at 6, 12, and 24 months were 16.8%, 41.4%, and 66%, respectively. Univariate analysis revealed that Graded Prognostic Assessment (P = .005), Score Index of Radiosurgery (P = .015), Recursive Partitioning Analysis (P = .011), the presence of primary cancer (P = .004), and localization (P = .048) significantly increased the incidence of RN. No significant relationship between RN and brain-gross tumour volume doses, planning target volume, fractionation, dose (P > .05). Multivariate analysis identified SIR > 6 (OR: 1.30, P = .021), primary of breast tumour (OR: 2.33, P = .031) and supratentorial localization (OR: 3.64, P = .025) as risk factors. Conclusions: SRT is used effectively in BMs. The incidence of RN following SRT is undeniably frequent. It was observed that the incidence rate increased as the follow-up period increased. We showed that brain-GTV doses are not predictive of RN development, unlike other publications. In study, a high SIR score and supratentorial localization were identified as factors that increased the risk of RN. Advances in knowledge: RN is still a common complication after SRT. Symptomatic RN is a significant cause of morbidity. The causes of RN are still not clearly identified. In many publications, brain dose and volumes have been found to be effective in RN. But, with this study, we found that brain dose volumes and fractionation did not increase the incidence of RN when brain doses were taken into account. The most important factor in the development of RN was found to be related to long survival after SRT.
引用
收藏
页码:1022 / 1028
页数:7
相关论文
共 36 条
[1]   Brain metastases [J].
Achrol, Achal Singh ;
Rennert, Robert C. ;
Anders, Carey ;
Soffietti, Riccardo ;
Ahluwalia, Manmeet S. ;
Nayak, Lakshmi ;
Peters, Solange ;
Arvold, Nils D. ;
Harsh, Griffith R. ;
Steeg, Patricia S. ;
Chang, Steven D. .
NATURE REVIEWS DISEASE PRIMERS, 2019, 5 (1)
[2]   IRRADIATED VOLUME AS A PREDICTOR OF BRAIN RADIONECROSIS AFTER LINEAR ACCELERATOR STEREOTACTIC RADIOSURGERY [J].
Blonigen, Brian J. ;
Steinmetz, Ryan D. ;
Levin, Linda ;
Lamba, Michael A. ;
Warnick, Ronald E. ;
Breneman, John C. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (04) :996-1001
[3]  
Buboltz JB., 2017, HYPERBARIC TREATMENT
[4]  
BUCHPIGUEL CA, 1995, J NUCL MED, V36, P159
[5]   Analysis of a Surgical Series of 21 Cerebral Radiation Necroses [J].
Campos, Benito ;
Neumann, Jan-Oliver ;
Hubert, Alexander ;
Adeberg, Sebastian ;
El Shafie, Rami ;
von Deimling, Andreas ;
Bendszus, Martin ;
Debus, Juergen ;
Bernhardt, Denise ;
Unterberg, Andreas .
WORLD NEUROSURGERY, 2020, 137 :E462-E469
[6]   TOXICITY CRITERIA OF THE RADIATION-THERAPY ONCOLOGY GROUP (RTOG) AND THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC) [J].
COX, JD ;
STETZ, J ;
PAJAK, TF .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (05) :1341-1346
[7]   Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis [J].
Donovan, E. K. ;
Parpia, S. ;
Greenspoon, J. N. .
CURRENT ONCOLOGY, 2019, 26 (03) :E328-E333
[8]   Conformity index:: A review [J].
Feuvret, L ;
Noël, G ;
Mazeron, JJ ;
Bey, P .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (02) :333-342
[9]   Brain metastases: epidemiology and pathophysiology [J].
Gavrilovic, IT ;
Posner, JB .
JOURNAL OF NEURO-ONCOLOGY, 2005, 75 (01) :5-14
[10]   Preliminary experience of the concurrent use of radiosurgery and T-DM1 for brain metastases in HER2-positive metastatic breast cancer [J].
Geraud, Arthur ;
Xu, Hao Ping ;
Beuzeboc, Philippe ;
Kirova, Youlia M. .
JOURNAL OF NEURO-ONCOLOGY, 2017, 131 (01) :69-72